ProfileGDS4718 / 242310_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 54% 12% 41% 63% 54% 50% 34% 51% 48% 52% 65% 40% 51% 53% 52% 42% 58% 42% 78% 45% 44% 47% 56% 62% 46% 67% 74% 60% 58% 43% 55% 41% 46% 45% 38% 49% 45% 40% 3% 42% 61% 56% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5548151
GSM549102patient 115, normal, homogenized [OPG study]5.7762354
GSM549104patient 119, normal, homogenized [OPG study]3.8212112
GSM549108patient 138, normal, homogenized [OPG study]5.0790141
GSM549119patient 077, normal, homogenized [OPG study]6.3392363
GSM549133patient 032, cancer, homogenized [OPG study]5.7000154
GSM549139patient 042, cancer, homogenized [OPG study]5.5002350
GSM549099patient 107, normal, homogenized [OPG study]4.7294334
GSM549109patient 139, normal, homogenized [OPG study]5.5925751
GSM549110patient 046, normal, homogenized [OPG study]5.3868548
GSM549114patient 063, normal, homogenized [OPG study]5.5739252
GSM549122patient 082, normal, homogenized [OPG study]6.5119765
GSM549134patient 033, cancer, homogenized [OPG study]4.9764340
GSM549136patient 036, cancer, homogenized [OPG study]5.5160851
GSM549140patient 044, cancer, homogenized [OPG study]5.653753
GSM549111patient 047, normal, homogenized [OPG study]5.6415652
GSM549113patient 057, normal, homogenized [OPG study]5.0352242
GSM549132patient 031, cancer, homogenized [OPG study]5.9566458
GSM549137patient 038, cancer, homogenized [OPG study]5.0808342
GSM549142patient 047, cancer, homogenized [OPG study]7.4563678
GSM549100patient 110, normal, homogenized [OPG study]5.2796545
GSM549107patient 135, normal, homogenized [OPG study]5.1407344
GSM549115patient 068, normal, homogenized [OPG study]5.2589647
GSM549116patient 072, normal, homogenized [OPG study]5.8837556
GSM549120patient 078, normal, homogenized [OPG study]6.2524862
GSM549131patient 030, cancer, homogenized [OPG study]5.2599646
GSM549118patient 074, normal, homogenized [OPG study]6.6249867
GSM549129patient 027, cancer, homogenized [OPG study]7.2553374
GSM549123patient 088, normal, homogenized [OPG study]6.1567260
GSM549124patient 006, cancer, homogenized [OPG study]6.0234958
GSM549126patient 015, cancer, homogenized [OPG study]5.1150243
GSM549128patient 025, cancer, homogenized [OPG study]5.8079755
GSM549103patient 117, normal, homogenized [OPG study]5.1199241
GSM549117patient 073, normal, homogenized [OPG study]5.2703846
GSM549138patient 041, cancer, homogenized [OPG study]5.2287845
GSM549141patient 045, cancer, homogenized [OPG study]4.8090438
GSM549130patient 028, cancer, homogenized [OPG study]5.4701249
GSM549101patient 111, normal, homogenized [OPG study]5.2838745
GSM549105patient 128, normal, homogenized [OPG study]4.9920340
GSM549106patient 134, normal, homogenized [OPG study]3.466573
GSM549112patient 048, normal, homogenized [OPG study]5.0559442
GSM549125patient 011, cancer, homogenized [OPG study]6.1664561
GSM549127patient 024, cancer, homogenized [OPG study]5.884456
GSM549135patient 035, cancer, homogenized [OPG study]5.5124350